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The antipsoriatic compound anthralin (1.8-dihydroxy-9- 
anthrone) is converted in skin into several oxidized products, 
including persistent free radicals that are not well character- 
ized. Anthralin oxidation was investigated by electron spin 
resonance spectroscopy in a biological system and in a chemi- 
cal system. Free radical formation in the skin of hairless mice 
is reduced by the antioxidant tocopherol. The data indicate 
that tocopherol acts by interfering with free radical forma- 
tion rather than by scavenging persistent anthralin radicals 
directly. The skin radicals do not correspond to IO-anthranyl, 
the initial paramagnetic anthralin oxidation product. Similar 
radicals obtained in skin are formed by anthralin exposed to 
ultraviolet light or alkaline solution and by mitochondria and 
microsomes. The pertinent skin radical is attributed to prod- 
ucts derived from anthralin dark structures, the final oxida- 
tion products of anthralin. It is suggested that resonance sta- 
bilized, paramagnetic polycyclic hydrocarbons are the 
compounds detected. Their stability and low reactivity indi- 
cate a low potential for cutaneous irritation and tumor pro- 
motion. Reactive oxygen species, which have been reported 
to be formed concomitantly during oxidation of anthralin, 
and the initially formed highly reactive lo-anthranyl radical 
are more potent candidates for mediating tumor promotion 
and inflammation. J Invest Dermatol92:677- 682, 1989 
A 
nthralin (1.8-dihydroxy-9-anthrone) is used for the 
topical treatment of psoriasis, a proliferative skin dis- 
ease [ 11. The drug inhibits respiration in keratinocytes 
[2] and influences numerous redox constituents and 
related metabolites [3]. Inflammatory cells in psoriasis 
(neutrophils and macrophages) are more sensitive than keratino- 
cytes to the action of anthralin [4]. Anthralin also inhibits leuko- 
triene production in human neutrophils [5]. Anthralin is a strong 
reductant that is readily oxidized by light, trace concentrations of 
metal ions, and oxygen. The initial oxidation product of anthralin is 
the 1.8-dihydroxy-9-anthrone-lo-y1 radical (IO-anthranyl), which 
is unstable and decomposes into higher oxidized reaction products 
[6]. The main metabolites in skin are 1.8.1’.8’.-tetrahydroxy- 
10. IO’.-9( IO)-dianthrone (anthralin dimer) and an ether insoluble 
oxidation product [i’] that is not well characterized chemically and is 
referred to as anthralin brown [8] or anthralin dark structures [9]. A 
naphthodianthrone [lO,ll] and other polycyclic aromatic hydro- 
carbons [9] are thought to comprise this product. Reactive oxygen 
species (singlet oxygen, superoxide anion radical) are formed as 
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Abbreviations: 
AL: asolectin 
CCCP: meta-chloro-cyanocarbonylphenylhydrazone 
DOTAB: dodecyltrimethylammonium-bromide 
ESR: electron spin resonance 
NAD: nicotine-adeninedinucleotide 
PA: phosphatidic acid 
PC: phosphatidylcholine 
SDS: sodium-dodecyl-sulfate 
UV/VIS: ultraviolet/visible 
reaction intermediates [ 12,131 d urm ’ g oxidation of anthralin. A per- 
sistent free radical has been detected in skin treated with anthralin 
[ 141, and it has been speculated that the IO-anthranyl radical was the 
species reported. Because of the discrepancies in the spectral charac- 
teristics and stability of the skin radical and the IO-anthranyl radical 
[ 15,161, we conducted this study in order to gain further insight into 
the nature of the free radical species detected in skin. 
MATERIALS AND METHODS 
Reagents Anthralin was obtained through Hermal Chemie 
(Reinbeck, West Germany). It was kept frozen in the dark and was 
purified by chromatography. Anthralin-dimer (1.8.1’.8’. -tetrahy- 
droxy-lO.IO’-bis-9(IO)-dianthrone) was a gift of Dr. Wiegrebe 
(University of Regensburg, West Germany); anthraquinone (1.8. 
-dihydroxy-9.1O.-anthraquinone), dl-alpha-tocopherol, 2.2’.-di- 
phenyl-l-picrylhydrazyl, sodium dodecylsulfate (SDS), TRITON 
X-100, rotenone, antimycin, and m-chloro-cyanocarbonylphenyl- 
hydrazone (CCCP) were purchased from Sigma Chemical Com- 
pany (St. Louis, MO). Hydrogenated l-a-lecithin (phosphatidyl- 
choline) and dipalmitoyl-phosphatidic acid were obtained through 
Avanti Polar Lipids, Inc. (Birmingham, AL); asolectin (AL) was 
purchased from Associated Concentrates (Woodside, NY); and do- 
decyltrimethylammonium bromide (DOTAE) was provided by 
Kodak Laboratory Chemicals (Rochester, NY). 
ESR Measurements First derivative electron spin resonance 
(ESR) spectra were recorded at ambient temperature on a Bruker ER 
200 D-SCR spectrometer (X-band) with 100 kHz modulation fre- 
quency. 2.2-diphenyl-1-picrylhydrazyl was used as the g factor ref- 
erence [17]. For the UV light studies, spectra were recorded on a 
Varian 109E ESR spectrometer (X-band, 100 kHz modulation fre- 
quency). Samples were illuminated within the ESR cavity using a 
1000 W Universal Xenon arc lamp, model 6140 (Oriel Corp, Con- 
necticut). The UV light was passed through a circulating water 
filter, three neutral density filters, and a 320 nm long pass filter 
(emission > 320 nm). The intensity of the light entering the spec- 
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trometer cavity was approximately 10 mW/cm*. Gas permeable 
Teflon tubing was purchased from Zeus Industrial Products Inc. 
(Raritan, NJ). 
Liposome Preparation Asolectin and phosphatidylcholine/ 
P 
hosphatidic acid liposomes (PC/PA) were prepared as described 
181. Asolectin was enriched with tocopherol prior to sonication, 
and tocopherol content of the liposomes was analyzed by high per- 
formance liquid chromatography (19). 
Biologic Samples Female hairless HRS/J mice, lo-12 weeks 
old (Jackson Laboratory, Bar Harbor, ME), kept on a standard diet 
with free access to food and water, were used. The animals were 
killed by cervical dislocation, the skin was manually separated from 
the body, and subcutaneous fat and fascia were removed by scrap- 
ping the dermal side with soft tissue paper. The epidermal/dermal 
skin sheet was washed free of blood with an isotonic, ice-cold buffer 
(sodium chloride 135 rnM, sodium phosphate 10 rnM, glucose 
5 mM, pH 7.0). The skin specimens were treated as explained in the 
figure legends. Four millimeter punch biopsies were cultured on 
glass wool pads (Type A/E, 47 mm; Millipore Corp., Bedford, MA) 
in 100 mm dishes [20,21]. The pads were well saturated with 10 ml 
of medium (Dulbecco’s Modified Eagle medium; Gibco, Grand 
Island, NY) containing 5% fetal calf serum (FCS; Whittaker M.A. 
Bioproducts, Walkersville, MD) without epidermal growth factor, 
0.4pg/ml hydrocortisone (Sigma), 1 nM cholera toxin (Sigma), 2.5 
pg/ml of a amphotericin B, penicillin, streptomycin and fungizone 
stock solution, and 1 .O pg/ml glutamine (Gibco). Care was taken to 
ensure that the medium did not overlap the surface of the cultures. 
Rat liver mitochondria and microsomes were prepared from female 
Fischer 344 rats (200-25Og), as previously described [22,23]. The 
viability of mitochondrial preparations was checked by oxypolarog- 
raphy. Only well-coupled mitochondria (ADP/O ratio = 3 for 
NAD dependent substrate) were used. Stratum corneum mem- 
branes were prepared from human callus material pulverized in 
liquid nitrogen. Student’s t-test for unpaired samples was used for 
the statistical evaluation. A probability (p) less than <0.05 was 
considered statistically significant. 
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Figure 1. Anthralin and its free radical products. 
RESULTS 
Anthralin Radicals in Biologic Systems Topical application of 
anthralin on excised skin of hairless mice results in the formation of 
products containing persistent free radicals (Fig 1). The radical con- 
centration in skin reaches a maximum at about 12 h after applica- 
tion and persists over the next 60 h. About one molecule of radical is 
formed per 500 molecules of anthralin. The antioxidant tocopherol 
significantly inhibits formation of anthralin radicals in skin when 
applied at the same time or 5 h after exposure of skin to anthralin 
(Fig 2). The ESR spectrum (Fig 3g) is characterized by an unresolv- 
able singlet (g = 2.0036, 1’ me width 6 G) that saturates at 5 mW 
half saturation power (Fig 4). A paramagnetic compound appears 
after addition of anthralin to a suspension of microsomes and well 
coupled mitochondria (g = 2.0036, line width 6 G) (Fig 5b). The 
radical formation is unaffected in mitochondria by inhibitors of 
electron transport (cyanide, antimycin), NAD-dehydrogenase 
blocker (rotenone), and uncouplers of oxidative phosphorylation 
(CCCP). No radicals were generated from anthraquinone (Fig SC) 
and anthralin dimer (Fig Sd). Likewise, in a control system, contain- 
ing an equivalent protein concentration of bovine serum albumin, 
no radicals were formed from anthralin. 
Anthralin Radicals in Chemical Systems Alkaline oxidation 
of the anthralin anion results in the sequential formation of different 
free radical species, distinguishable by ESR spectroscopy (Fig 3a-d). 
The radical that is initially detected (primary radical, g = 2.0036, 
line width 1.2 G) shows a quintet resonance signal (Fig 3a). At 
lower modulation amplitude a superhyperfine structure can be re- 
solved (twenty-five lines, line width 0.2 G) (Fig 3b), which changes 
in ethanol into a less complex spectrum (Fig 3~). Visible and ultravi- 
olet spectra of anthralin in 1 N sodium hydroxide (15 min) demon- 
strate absorption maxima of 500.5 and 286.7 nm in comparison to 
356.4 and 287.9 nm for anthralin in a physiological buffer. The 
primary radical is converted over a period of several hours into a 
secondary unidentified radical (Fig 3d) that undergoes further con- 
version into a stable tertiary radical (g = 2.0036, line width about 
6 G) with a broad, unresolvable asymmetric singlet structure (Fig 
3e). At this time, a black-brown precipitate is formed. Anthralin 
dark structures obtained as the ether insoluble oxidation product of 
anthralin dimer [9] contain stable free radicals (g = 2.0035, line 
width 6 G) characterized by a broad, unresolvable singlet resonance 
line (Fig 3f). 
Interaction of the primary radical with asolectin and stratum cor- 
neum membranes revealed a significant immobilization of the free 
+ tocopherol, 0 hrs 
0 20 40 60 80 
Time (hours) 
Figure 2. Radical formation in skin treated with anthralin. Four-milli- 
meter punch biopsies were treated with 0) anthralin (3.5 ~1 of 100 mM 
anthralin in chloroform), b) anthralin plus tocopherol (3.5 ,~l of 100 mM 
anthralin, 3.5 ,~l of 100 mM tocopherol in chloroform 5 h after application 
of anthralin), and c) anthralin plus tocopherol (tocopherol shortly after ap- 
plication of anthralin). Mean values of four animals plus/minus SD are 
displayed. Differences between the anthralin treated skin biopsies and 
anthralin plus tocopherol (after 5 h) and plus tocopherol (applied at the same 
time) are significant with p < 0.05 at 12 h. Instrument settings: 1.25 G 
modulation, 10 mW microwave power, 0.5 G/s scan time, 5 X 10s gain. 
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a) Anthralin/NaOH 
15 min 
c) Anthralin/NaOH/ethanol 
15 min 
e) Anthralin/NaOH 
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Figure 3. Formation of different anthralin radicals. Anthralin (100 mM) 
was oxidized in 1N NaOH (a-d) . a: 15 min reaction time; b: as in a but at 
0.5 G modulation to show superhyperfine structure; c: as in b but 50% 
ethanol; d: 24 h; e: 120 h; $ anthralin dark products (anthralin brown); 
2: skin radical. Instrument settings: 1.0 G modulation (0.5 G as indicated), 
10 mW microwave power, 0.5 G/s scan time, 2.0-8 X 10s gain. Experi- 
ments were repeated at least five times, representative spectra are shown. 
radical with phospholipid membranes only (Fig 6b). Application of 
the primary radical on skin of hairless mice resulted instantaneously 
in interconversion into the tertiary radical (g = 2.0036, line width 
6 G), (Fig 6~). 
Free radicals can be detected during photooxidation of anthralin. 
Initially, a triplet signal is recorded (Fig 7a), which changes subse- 
quently into a singlet (g = 2.0036, line width 6 G). Radical forma- 
tion is inhibited under nitrogen (illumination in gas permeable tub- 
ings) and is enhanced by increasing the oxygen concentration. The 
same radical species are formed from anthralin dimer at a tenfold 
lower concentration. No radicals could be detected during irradia- 
tion of anthraquinone. Photo-oxidation of anthralin in liposomes 
and micelles results in formation of a radical with an unresolvable 
3 
1 
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0: , , , , , 1 
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Figure 4. Power saturation of skin radicals. Signal intensity (SJ of the skin 
radical was measured as a function of the microwave power (p). Half satura- 
tion power (5 mW) is indicated by the crossing point of the tangents. Mean 
values of three measurements are shown. Instrument settings: 1.0 G modu- 
lation, 0.5 G/s scan time. 
b) Anthralin 
c) Anthraquinone 
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Figure 5. Oxidation of anthralin by mitochondria. ESR spectra obtained 
from a) rat liver mitochondria (40 mg protein per ml sucrose 135 mM, NaPi 
10 mM, Tris-HC1 1.0 mM), b) anthralin (1 mM), c) anthraquinone 
(1 mM), and d) anthralin dimer (1 mM) plus mitochondria. Instrument set- 
tings: 1.25 G modulation, 10 mW microwave power, 1 G/s scan time, gain 
1.25 X 106. Representative spectra of four experiments using different mi- 
tochondrial preparations are shown: spectra were recorded continuously 
over 5 min. 
singlet signal (g = 2.0036, line width 6 G), (Fig 74. Radicals could 
be detected in the aqueous system at a 50 times lower concentration 
of anthralin than in non-aqueous solvents. The radical yield is in- 
creased by enriching the liposomes with tocopherol (Fig 8). In 
tocopherol free phosphatidylcholine/phosphatidic acid liposomes 
(PC/PA), no anthralin radicals are formed photochemically. Of the 
a) Stratum corneum membranes b) Asolectin liposomes 
c) Skin 
d) Skin control 
Figure 6. Membrane interactions of anthralin radicals. a: An aliquot (2 ~1) 
of anthralin in alkaline solution (100 mM, 15 min reaction time) was added 
to a suspension of 100 ~1 stratum corneum membranes in phosphate buffer 
(50 mg/ml); b: to 100 ~1 asolectin liposomes (50 mg/ml); c: on a 4 mm skin 
biopsy; d: 2 ~1 anthralin in chloroform (100 mM) on a 4 mm skin biopsy. 
Spectra were recorded immediately afterwards. Experiments were repeated 
five times; representative spectra are shown. Instrument settings: 1.25 G 
modulation, 10 mW microwave power, 0.5 G/s scan time, gain 2 - 8 X 105. 
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a) Anthralin 50 mM/chloroform 
5 min 
b) Anthralin 50 mM/chloroform 
30 min 
c) Anthralin 1 mU/asolectin liposomes 
5 min 
Figure 7. Photooxidation of anthralin in organic solvents and liposomes. 
Instrument settings: 1 .O G modulation, 10 mW microwave power, 0.1 G/s 
scan time, gain 10 X 10’. Sample illuminated by a 1000 W Xenon UV lamp 
at 30 A power. Experiments were repeated at least four times; representative 
spectra are shown. 
three micellar systems tested, anthralin was photo-oxidized to radi- 
cals only in DOTAB micelles (Fig 8). 
DISCUSSION 
Characterization of Anthralin Free Radicals The spectrum of 
the IO-anthranyl radical obtained by thermolysis of anthralin dimer 
in xylene [ 151 and by anthralin oxidation through peroxidized lipids 
[ 161 is neither compatible with the ESR signal recorded for the skin 
radical (Fig 3g) nor with the primary or tertiary radical (Fig 3a, d, e). 
The visible and ultraviolet spectrum of anthralin in alkaline solu- 
tion, obtained after 15 min reaction time, reveals a complete oxida- 
tion of anthralin (UV max 288/356 nm) into a dianthrone or 
naphthodianthrone species (UV/VIS max 287/500 nm) [9,24]. 
The primary radical can probably be assigned to a paramagnetic 
Figure 8. Photo-oxidation of anthralin in liposomes and micelles. Anthra- 
lin (1 mM) in ethanol, asolectin liposomes (ASO) (20 mg asolectin/rnl 
buffer, tocopherol content 25 uM), asolectin liposomes with increased to- 
copherol content of 1 mM (AS0 1) or 10 mM (AS0 10). TRITON 
(50 mM, NaPi 100 mM, pH 7.0), SDS (50 mM, NaPi 100 tnM, pH 7.0). 
DOTAB (50 mM, NaPi 100 mh4, pH 7.0), phosphatidylcholine/phospha- 
tidic acid (PC/PA) liposomes (50 mM 1: 1, NaPi 100 mM, pH 7.0). Repre- 
sentative spectra of five experiments are shown. Instrument settings: 1.0 G 
modulation, 10 mW microwave power, 1 G/s scan time, gain 2.5 X 10’. 
UV illumination as in Fig 6. 
dianthrone species (anthralin dimer radical; see Fig 1) that shows 
similar spectral characteristics [25,26]. The unsymmetrical signal of 
the tertiary radical implies the presence of more than one species. It 
corresponds to paramagnetic compounds found in anthralin dark 
products (anthralin brown, carbon black) [27]. Naphthodianthrone 
and higher polycyclic aromatic hydrocarbons have been identified 
as components of anthralin dark product [9]. Anthralin dark struc- 
tures were synthesized by oxidation of anthralin dimer [lo] and 
were shown to contain radicals with similar spectral characteristics 
(Fig 3f) as the tertiary and skin radical. 
A radical with identical spectral characteristics is also formed by 
mitochondria, microsomes, and photo-oxidation of anthralin in li- 
posomes (Figs 5b and 7~). The ESR signal of the skin radical resem- 
bles the spectrum recorded for the final oxidation products of 
anthralin in lipid peroxides [ 151. These compounds are formed from 
the reaction intermediate anthralin-dimer [15] and correspond to 
anthralin dark products, which were identified as the main metabo- 
lites in skin during long-term anthralin treatment [5]. We suggest 
that the paramagnetic compound detected in skin resembles a reso- 
nance stabilized radical of a polycyclic aromatic hydrocarbon, like 
anthralin brown (naphthodianthrone) or carbon black (see scheme) 
[9]. Enhanced autoxidation as well as non-enzymatic or enzymatic 
oxidation mechanisms might play a role in the radical generation 
process in skin. Autoxidation of anthralin in skin could be enhanced 
by proteins [28], and non-enzymatic oxidation was shown to be 
mediated by peroxidized lipids [14]. Metabolic conversion of 
anthralin into paramagnetic oxidation products could also conceiva- 
bly occur through redox active enzymes in keratinocyte plasma 
membranes, mitochondria, or microsomes. At the moment, how- 
ever, we cannot provide any experimental evidence of an enzymatic 
oxidation mechanism in skin. The mechanism of anthralin oxida- 
tion through mitochondria and microsomes remains unsolved. The 
results indicate that mitochondrial anthralin oxidation is neither an 
ATP dependent process nor coupled to the normal electron flow of 
the electron transport chain. Radical generation through enhanced 
autoxidation of anthralin by the mitochondrial/microsomal protein 
[21] is unlikely, because albumin did not facilitate anthralin radical 
formation. Additional studies indicate that anthralin is oxidized by 
mitochondrial ubiquinones and iron sulfur proteins (unpublished 
data). 
It was speculated that the broad ESR signal detected in skin corre- 
sponded to the IO-anthranyl radical bound to epidermal biopoly- 
mers [14]. We report that the g value of the skin signal (g = 2.0036) 
is different from the g value of the IO-anthranyl (g = 2.0028). This 
is in contrast to a previous report (g = 2.0029) [14]. Membrane 
binding does not explain the large shift in the g value. The primary 
radical, supposedly of dianthrone structure (anthralin dimer type), is 
the reaction product of the initially formed IO-anthranyl, which 
was undetectable in our experiments. Application of the primary 
radical on skin results instantaneously in an interconversion of the 
five line spectrum into a broad singlet (Fig 6a, c). The spectrum of 
the primary radical is only slightly distorted by interaction with 
phospholipid membranes (Fig 6b), but not with stratum corneum 
membranes (Fig 6a), mainly composed of proteins. The hyperfine 
structure can still be resolved in lipid membranes. It is suggested that 
the interconversion of the spectrum is not due to membrane binding 
of the primary radical but rather to redox properties of the skin. 
In organic solvents, radical formation was demonstrated to be a 
photodynamic process. The generation of reactive oxygen species 
by anthralin is already known [9,12,13]. A fiftyfold higher anthralin 
concentration was required in chloroform than in liposomes to yield 
a detectable radical concentration. The photochemical formation of 
anthralin radicals is enhanced in asolectin liposomes by increasing 
the tocopherol content (asolectin contains about 0.5 pg tocopherol 
per mg lipid). This is consistent with the pro-oxidative behavior of 
the photochemically formed tocopheroxyl radical in liposomes (as 
detected by ESR spectroscopy) [29] that oxidizes anthralin to para- 
magnetic products. In tocopherol free liposomes (phosphatidylcho- 
line/phosphatidic acid) no photochemical radical formation is ob- 
served. In the micellar systems tested, radicals were only detected in 
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positively charged DOTAB but not in negatively charged SDS and 
in neutral TRITON micelles. It is concluded that radical initiators, 
surface structure, and solvent characteristics are critical factors in 
anthralin radical generation. 
Clinical Implications of Anthralin Free Radicals Anthralin 
caused inflammation can clinically be inhibited by topical applica- 
tion of free radical scavengers such as tocopherol [3O]. It was sug- 
gested that anthralin inflammation may at least partially be me- 
diated by activated oxygen species or the highly reactive 
IO-anthranvl radical. Toconherol scavenees suneroxide anion radi- 
cals [31], sihglet oxygen [;2], and lipid ieroxides [33]. We found 
that tocopherol does not scavenge the primary anthralin radical or 
the tertiary radical. However, tocophe;ol inhibits the formation of 
radicals in skin treated with anthralin. Concomitant treatment of 
skin with both compounds as well as subsequent application of 
tocopherol resulted in reduction of produced radicals. In the latter 
case, anthralin already partitioned into the skin tissue, and a degra- 
dation of anthralin through tocopherol [34] is quite unlikely. 
Rather it is concluded that the antioxidant interferes with radical 
initiation mechanisms or reacts with the highly reactive, initially 
formed IO-anthranyl radical than by scavenging the persistent 
anthralin derived radicals directly. 
Evidence is increasing that free radicals play an important role in 
tumor promotion [35,36]. Anthralin is a tumor promoter [37-391; 
however, antimutagenic potency was recently reported [40,41]. Ac- 
tivated oxygen species are generated during oxidation of anthralin 
[9,11], and superoxide dismutase and catalase activity are inhibited 
[42]. A pro-oxidant state is caused that can promote initiated cells to 
neoplastic growth [43]. In contrast to activated oxygen species and 
to highly reactive IO-anthranyl radicals, the presence of a persistent 
skin radical rather indicates a low reactivity of this compound 
towards sensitive cellular components. The biological role of this 
persistent skin radical remains to be determined. 
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SYMPOSIUM AND O’LEARY MEETING 
The First International Parapsoriasis Symposium will be held at the Mayo Clinic, Rochester, 
Minnesota, September 7 and 8, 1989. Outstanding clinicians and dermatological scientists will 
present scientific papers and discuss both basic and applied clinical research and its application to 
patients afflicted with guttate parapsoriasis (pity&is lichenoides) and its variants. 
A reduced registration fee of $50 is made possible by the generous educational funding of the 
Phillips Foundation. Registrants of the International Parapsoriasis Symposium are invited to 
attend the 17th Biennial O’Leary Meeting which will follow the International Parapsoriasis 
Symposium on September 9 and 10, 1989. Saturday’s session will consist of various topics of 
major dermatological interest presented by the Mayo Clinic Staff followed by the 17th Paul A. 
O’Leary Lecture. The session Sunday, September 10, will consist of clinical case presentations 
presented by the Department of Dermatology, Mayo Clinic, sponsored also by the Minnesota 
Dermatological Association. 
The registration fee for the O’Leary meeting is $125. Please contact Sigfrid A. Muller, M.D., 
Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905. 
